National

COVID-19: FDA approves experimental treatment.US reports 195,500 new cases

November 21st – The US Food and Drug Administration approved the use of monoclonal antibodies for the treatment of COVID-19 on Saturday, reporting the highest number of new infections and the highest number of hospitalizations.

On Saturday, the FDA announced that it has issued an Emergency Use Permit (EUA) for the treatment of mild to moderate COVID-19 in adults and pediatric patients aged 12 years and older, co-administering kacilibimab and imdebimab.

“Urgent approval of these monoclonal antibodies co-administered provides healthcare providers with another tool to combat pandemics,” said Patrizia Cavazzoni, MD, Deputy Director of the FDA’s Center for Drug Evaluation and Research, in a release. Said.

President Donald Trump received an infusion of Regeneron’s clinical trial cocktail on October 2, after being diagnosed with the virus, but is initially expected to run out of medication.

Approval has taken place in almost every state reporting a surge in incidents, and public health officials have unearthed evidence that the Sturgis Motorcycle Rally in South Dakota in August caused outbreaks elsewhere in the country. I’m continuing.

On Friday, more than 195,500 new infections were recorded nationwide, and 82,178 were hospitalized for the disease.

Both of these numbers set new records in the United States, with the number of new cases at 77,100, more than double the new numbers recorded in July during the summer surge.

In November alone, 2.7 million new infections were recorded in the United States, with more than 10,000 COVID-19 deaths reported in the past week.

According to the Johns Hopkins University COVID-19 tracker, the country has now recorded approximately 12 million cases and 255,098 deaths since the pandemic began.

In almost every state and U.S. territory, new daily cases have increased in recent weeks, but in many states the virus has become so prevalent that elected officials appear to have taken place this spring. Countries that are reluctant to impose jurisdiction over large-scale curfew.

This week, the Centers for Disease Control and Prevention released a report identifying a 10-day Sturgis rally (460,000 people attended without restrictions or closures) as the cause of the outbreak in Minnesota. A place to control the spread of the virus.

Minnesota’s public health sector infected at least 51 Minnesota residents who attended a rally and became ill, and subsequently infected an additional 35 (home, social, and workplace contacts) who did not attend the event. I found that.

Of the 86 sick, four were hospitalized and one died.

The CDC provided a snapshot of the impact of the rally on other states, with the report’s findings affecting Minnesota, where one-third of the state counties had at least one rally-related incident. He said he may have underestimated.

This report comes when Americans are thinking about vacation trips and shopping, and when public health professionals reiterate the importance of wearing masks and social distance.

The CDC strongly recommends avoiding Thanksgiving trips and Black Friday congestion, and this week announced a brief Friday on the effectiveness of cloth masks to prevent the spread of the virus.

“Masks are primarily intended to reduce the emission of droplets containing viruses (” source control “). This is especially relevant for asymptomatic or pre-symptomatic infected wearers who feel good and may not be aware of their infectivity to others and are presumed to explain. About 50% or more of transmissions. “

Officials elected in the local elections of both parties were reluctant to resume the type of radical closure that began in the spring, but rhetoric is slowly changing in some areas.

Republican Governor Kim Reynolds of Iowa issued a state-wide mask order this week after claiming that such measures were unenforceable and useless.

“If Iowa disagrees with this, we lose,” said Reynolds, who has the sixth highest new case rate in the country. “The cost of human life will be high.”



COVID-19: FDA approves experimental treatment.US reports 195,500 new cases

Source link COVID-19: FDA approves experimental treatment.US reports 195,500 new cases

Back to top button